NovaBay Pharmaceuticals I...

AMEX: NBY · Real-Time Price · USD
0.55
-0.05 (-9.06%)
At close: Aug 15, 2025, 3:30 PM
0.62
13.30%
After-hours: Aug 15, 2025, 03:58 PM EDT

NovaBay Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
8.47M 430K 776K 751K 1.82M 3.13M 3.47M 4.41M 3.75M 5.36M 3.87M 3.93M 5.64M 7.5M 9.03M 10.29M 10.51M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 476K 476K 476K 476K 476K 476K 484K 152K 155K 152K 475K 475K 475K 475K
Other Long-Term Assets
479K 42.96M 495K n/a 1K 21K 501K 496K 478K 489K 153K 156K 161K 476K n/a n/a 1K
Receivables
n/a 389K 704K 547K 734K 759K 916K 2.62M 1.83M 1.97M 2.13M 1.1M 2.3M 1.67M 843K 1.23M 1.36M
Inventory
n/a 765K 473K 700K 663K 2.88M 3.49M 3.66M 3.8M 3.44M 4.07M 3.8M 3.79M 3.22M 969K 682K 850K
Other Current Assets
10K 158K 116K 94K 96K 81K 72K 197K 132K 159K 109K 151K 228K 144K 117K 97K 131K
Total Current Assets
9.04M 1.94M 2.28M 2.25M 3.59M 7.15M 8.21M 11.22M 9.89M 11.33M 10.61M 9.46M 12.48M 13.17M 11.5M 12.77M 13.15M
Property-Plant & Equipment
355K 1.01M 1.1M 1.2M 1.29M 1.38M 1.62M 1.74M 1.86M 1.95M 2.15M 2.38M 2.52M 604K 266K 356K 450K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a 2.51M 2.55M 2.59M 2.63M 9.46M 9.55M 9.64M 9.73M n/a n/a n/a
Total Long-Term Assets
834K 43.97M 1.6M 1.67M 1.77M 1.88M 4.64M 4.79M 4.93M 5.07M 11.76M 12.09M 12.32M 10.81M 741K 831K 926K
Total Assets
9.87M 3.42M 3.88M 3.92M 5.36M 9.03M 12.85M 16.01M 14.82M 16.4M 22.38M 21.54M 24.79M 23.98M 12.24M 13.6M 14.07M
Account Payables
800K 623K 396K 1.24M 1.12M 1.13M 947K 1.48M 1.15M 1.08M 1.1M 930K 1.56M 1.04M 1.35M 208K 833K
Deferred Revenue
n/a 488K n/a 773K 745K 946K 1.04M 1.82M 1.86M 1.81M 1.7M 1.47M 1.91M 1.29M 579K 943K 862K
Short-Term Debt
84K 565K 51K 1.08M 1.01M 1.63M 1.75M 1.66M 466K n/a 445K 470K 465K 305K 195K 298K 396K
Other Current Liabilities
175K 172K 859K 535K 1.12M 680K 962K 69K 154K n/a -544K -450K -26K 320K 310K 442K 656K
Total Current Liabilities
3.07M 2.84M 1.98M 3.61M 3.92M 4.28M 4.57M 6.07M 4.42M 4.26M 3.71M 3.66M 4.78M 3.44M 2.87M 2.39M 3.08M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a 232K 334K n/a n/a n/a n/a 3.17M 342K 342K 10.12M n/a n/a n/a
Total Long-Term Liabilities
638K 709K 821K 932K 1.27M 1.44M 1.24M 1.38M 1.51M 1.59M 4.88M 2.14M 2.26M 10.37M 1K 5K 9K
Total Liabilities
3.71M 3.55M 2.81M 4.54M 5.2M 5.72M 5.82M 7.45M 5.93M 5.84M 8.59M 5.8M 7.05M 13.81M 2.88M 2.39M 3.09M
Total Debt
1.13M 1.67M 1.26M 2.01M 2.42M 2.74M 3M 3.04M 1.98M 2.04M 2.16M 2.27M 2.39M 551K 196K 303K 405K
Common Stock
58K 49K 49K 13K 320K 112K 65K 673K 652K 652K 650K 535K 514K 478K 450K 447K 418K
Retained Earnings
-175.79M -183.46M -182.25M -180.03M -178.44M -174.85M -165.68M -163.92M -159.89M -158.15M -149.95M -144.15M -142M -141.89M -141.73M -139.44M -137.58M
Comprehensive Income
n/a n/a n/a -6K -44K -112K -302K -449K -0.00 n/a n/a -0.00 -0.00 -680K 0.00 n/a n/a
Shareholders Equity
6.17M -129K 1.07M -617K 160K 3.31M 7.04M 8.56M 8.89M 10.55M 13.78M 15.74M 17.75M 10.17M 9.36M 11.21M 10.98M
Total Investments
n/a n/a n/a 476K 476K 476K 476K 476K 476K 484K 152K 155K 152K 475K 475K 475K 475K